Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole vs Goserelin for Uterine Adenomyosis
NCT01218581Phase 3Completed
- Sponsor
- Mansoura University
- Start
- Dec 2005
- Primary completion
- Jan 2010
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of letrozole in uterine adenomyosis (2 arms), sponsored by Mansoura University. Primary endpoints: Uterine Volume at 12 weeks and Adenomyoma Volume at 12 weeks. Started Dec 2005; status: completed.
02
Drugs
letrozole
03
Conditions
uterine adenomyosis
Beyond the preview
Go deeper on NCT01218581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01218581.